kras mutation and glutathion glynac

kras mutation and glutathion glynac Oncogenic Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell Isoform-Specific Destabilization of the Active

Name: kras mutation and glutathion glynac Oncogenic Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell Isoform-Specific Destabilization of the Active
Brand: www.marsberger-treibhaus.de
SKU: 19980302485
Price: 26.37 USD
Availability: InStock
Rating: 4.2115 (24 reviews)

Isoform Specific Destabilization of the Active Site Reveals a Molecular Mechanism of Intrinsic Activation of KRas G13D: Cell Reports Metabonomics study of the effects of single copy mutant KRAS in the presence or absence of WT allele using human HCT116 isogenic cell lines Metabolomics Springer Nature Link Oncometabolites in pancreatic cancer: Strategies and its implications PMC KRAS G12 mutant alleles differentially control glutamine metabolism via FOXO1 bioRxiv

SKU: 19980302485 · From www.marsberger-treibhaus.de

4.2

USD26.37 USD65.37

Pay in 4 interest-free payments of $6.59 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 30 - Aug 4

Description

OCA treatment ameliorated high-fat diet (HFD)-induced dysplasia, potentially by reducing deleterious secondary BAs (e.g., DCA, TDCA), decreasing microbial bile salt hydrolase (BSH) expression, and favorably reshaping the tumors immune landscape (128), thereby potentially reversing an immunosuppressive TIME